PhoreMost Raises $46M in Series B Financing

25 Mar, 2021

PhoreMost Raises $46M in Series B Financing
Photo by Dan Schiumarini on Unsplash

– PhoreMost is a Cambridge, England, UK-based biopharmaceutical company.
– The company raised $46m in Series B funding.
– The round was led by BGF, and included new investor – XtalPi Inc., Astellas Venture Management, Trend Investment Group, and o2h ventures.
– Existing investors Parkwalk Advisors, Morningside Ventures, and Jonathan Milner also contributed.

Biopharma Biotechnology Europe Health Care
Crunchbase icon

Content report

The following text will be sent to our editors: